13F Data
13F filer · CIK 1602263

VHCP Management II, LLC

New York, NY · filing since Q4 2015 · last filing Feb 13, 2020
Reported value
$379.4M
+$116.9M vs prior
Positions
20
New / sold out
8 / 9
Added / reduced
1 / 7
Turnover
20.8%
buys $66.6M · sells $107.3M
Top-10 weight
94.1%

Biggest buys vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
AddedConstellation Pharmaceuticals+773,954+106.5%+$36.5M
NewIveric Bio Inc+1,004,299–+$8.6M
NewMersana Therapeutics Inc+922,514–+$5.3M
NewRelmada Therapeutics Inc+114,876–+$4.5M
NewAdverum Biotechnologies Inc+383,620–+$4.4M
NewForty Seven Inc+77,714–+$3.1M
NewNextcure Inc+36,249–+$2.0M
NewMyovant Sciences Ltd+76,768–+$1.2M
New89Bio Inc+41,235–+$1.1M

Biggest sells vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
Sold outAscendis Pharma A/S-234,591-100.0%$-22.6M
Sold outRa Pharmaceuticals-677,164-100.0%$-16.0M
ReducedShockwave Medical Inc-357,589-55.3%$-15.7M
ReducedBiohaven Pharmaceuticals-250,000-35.1%$-13.6M
ReducedAxsome Therapeutics Inc-106,965-12.0%$-11.1M
Sold outBioCryst Pharmaceuticals Inc-2,874,602-100.0%$-8.2M
Sold outKiniksa Pharmaceuticals Ltd-540,461-100.0%$-4.6M
Sold outLa Jolla Pharmaceuticals-518,102-100.0%$-4.6M
Sold outTricida Inc-118,886-100.0%$-3.7M
ReducedProtagonist Therapeutics Inc-394,570-92.5%$-2.8M
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $121.7MQ1 2016: $152.0MQ2 2016: $165.7MQ3 2016: $194.8MQ4 2016: $208.5MQ1 2017: $244.4MQ2 2017: $250.4MQ3 2017: $361.9MQ4 2017: $417.2MQ1 2018: $414.4MQ2 2018: $334.1MQ3 2018: $374.5MQ4 2018: $233.0MQ1 2019: $341.8MQ2 2019: $317.2MQ3 2019: $262.4MQ4 2019: $379.4M
Q4 2015Q4 2019

Holdings · Q4 2019

#SecuritySharesValueWeight
110X Genomics Inc.COM1,786,431$136.2M35.91%
2Axsome Therapeutics IncCOM785,981$81.2M21.42%
3Constellation PharmaceuticalsCOM1,500,631$70.7M18.64%
4Biohaven PharmaceuticalsCOM462,903$25.2M6.64%
5Shockwave Medical IncCOM288,838$12.7M3.34%
6Iveric Bio IncCOM1,004,299$8.6M2.27%
7Kalvista PharmaceuticalsCOM366,268$6.5M1.72%
8Obseva SACOM1,573,639$6.0M1.58%
9Mersana Therapeutics IncCOM922,514$5.3M1.39%
10Spero Therapeutics IncCOM474,015$4.6M1.20%
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.